# Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/investigating-novel-resistance-mechanisms-to-third-generation-egfr-tyrosine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Zhe Yang,Nong Yang,Qiuxiang Ou,Yi Xiang,Tao Jiang,Xue Wu,Hua Bao,Xiaoling Tong,Xiaonan Wang,Yang Shao,Yunpeng Liu,Yan Wang,Caicun Zhou |
| Citations | 549 |
| DOI | 10.1158/1078-0432.ccr-17-2310 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2790922923 |
| PMID | 29506987 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Nong Yang](https://scholariq.org/researchers/nong-yang/)
- [Tao Jiang](https://scholariq.org/researchers/tao-jiang/)
- [Yan Wang](https://scholariq.org/researchers/yan-wang/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.